The company`s annual report informs that this years annual net profit to be around 115 crores.On a equity of 15.6 crores this translates to a eps of about 7 on 1 paid up share.At 22 this share is highly undervalued and the promoters hold 60%.I think this share can easily reach 35-40. even at that price the pe will be about 5.Does anyone agree to this?
I for one agree with you, otherwise why would I hold it? May be because of the indifferent management or because of the pharma sector it is languishing at 22 or less.
catch if you can
because i see lots of buying in this script
so it will zoom and it will touch ariound 42 to 45 rs in no time
whats your advice on this stock and whats your call on this nectar life
please reply sir
catch if you can
because i see lots of buying in this script
so it will zoom and it will touch ariound 42 to 45 rs in no time
whats your advice on this stock and whats your call on this nectar life
please reply sir
| NIFTY 
